Diagnamed Holdings Corp.
DMED
CNSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 608.59% | 12.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 252.73% | 85.44% | |||
| Operating Income | -252.73% | -85.44% | |||
| Income Before Tax | -148.88% | -72.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -148.88% | -72.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -148.88% | -72.52% | |||
| EBIT | -252.73% | -85.44% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -105.00% | -66.67% | |||
| Normalized Basic EPS | -141.67% | -71.43% | |||
| EPS Diluted | -105.00% | -66.67% | |||
| Normalized Diluted EPS | -141.67% | -71.43% | |||
| Average Basic Shares Outstanding | 19.48% | 2.92% | |||
| Average Diluted Shares Outstanding | 19.48% | 2.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||